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Abstract Aquaculture is becoming the primary
source of seafood for human diets, and farmed fish
aquaculture is one of its fastest growing sectors. The
industry currently faces several challenges including
infectious and parasitic diseases, reduced viability,
fertility reduction, slow growth, escapee fish and
environmental pollution. The commercialization of
the growth-enhanced AquAdvantage salmon and the
CRISPR/Cas9-developed tilapia (Oreochromis niloti-
cus) proffers genetic engineering and genome editing
tools, e.g. CRISPR/Cas, as potential solutions to these
challenges. Future traits being developed in different
fish species include disease resistance, sterility, and
enhanced growth. Despite these notable advances, off-
target effect and non-clarification of trait-related genes
among other technical challenges hinder full realiza-
tion of CRISPR/Cas potentials in fish breeding. In
addition, current regulatory and risk assessment
frameworks are not fit-for purpose regarding the
challenges of CRISPR/Cas notwithstanding that pub-
lic and regulatory acceptance are key to commercial-
ization of products of the new technology. In this
study, we discuss how CRISPR/Cas can be used to
overcome some of these limitations focusing on
diseases and environmental release in farmed fish
aquaculture. We further present technical limitations,
regulatory and risk assessment challenges of the use of
CRISPR/Cas, and proffer research strategies that will
provide much-needed data for regulatory decisions,
risk assessments, increased public awareness and
sustainable applications of CRISPR/Cas in fish aqua-
culture with emphasis on Atlantic salmon (Salmo
salar) breeding.
Keywords CRISPR/Cas  Aquaculture  Salmon 
Risk assessment  Sustainability  Genome-editing 
Gene modification  Genetically modified organism 
GMO
Arinze S. Okoli and Torill Blix have contributed equally to this
work.
A. S. Okoli (&)  T. Blix  A. I. Myhr




The Norwegian College of Fishery Science, The Arctic
University of Norway (UiT), Tromsø, Norway
W. Xu
Yellow Sea Fisheries Research Institute, Chinese
Academy of Fishery Sciences, Qingdao 266071, China
X. Xu






Trends in application of CRISPR/Cas in fish
aquaculture
Aquaculture industries worldwide are experiencing
pressing challenges including infectious and parasitic
diseases, reduced viability, fertility reduction, slow
growth, escapee fish, environmental pollution, coastal
conflicts, and disputes regarding patenting of research
outputs (Ahmed et al. 2019; Gratacap et al. 2019b).
The commercialization of the growth-enhanced
AquAdvantage salmon (AAS) for food in 2016 in
Canada and 2019 in USA (Sweet 2019), and Nile
tilapia (Oreochromis niloticus) in 2018 in Argentina
(Evans 2018) showed that genetic engineering can
proffer solutions to some of these challenges. The
AASwas produced using a classical gene modification
(GM) technique whereby an Atlantic salmon (Salmo
salar) egg was modified with a gene construct
containing Chinook salmon (C. Salmon) (On-
corhynchus tshawytscha) growth hormone gene
placed under the anti-freeze protein promoter of an
Ocean pout (Macrozoarces americanus) (Leggatt
2013). The tilapia was modified using the more recent
genome editing (GE) technique, CRISPR/Cas9 (clus-
tered regularly interspaced short palindromic repeats/
CRISPR-associated protein 9), but information on the
exact modification is presently not publicly available
(Evans 2018). The advent of these more efficient and
cheaper GE techniques, especially CRISPR/Cas, has
led to GE being proposed as a potential solution to
several of the current challenges of the aquaculture
industry. The most targeted traits (Blix et al. 2021) for
GE in fish aquaculture are reproduction and develop-
ment (eg. Jin et al. 2020; Straume et al. 2021), growth
(eg. Sun et al. 2020), pigmentation (eg. Xu et al. 2019;
Chen et al. 2019), disease resistance (eg. Kim et al.
2021), use of trans-GFP in research (eg. Gratacap et al.
2020) and omega-3 metabolism (eg. Datsomor et al.
2019a, b).
In several studies CRISPR/Cas9 have been used to
edit different genes in Atlantic salmon (Datsomor
et al. 2019a, b; Edvardsen et al. 2014; Güralp et al.
2020; Straume et al. 2020, 2021; Wargelius et al.
2016) aimed at mitigating some of the problems of
salmon aquaculture. For example, CRISPR/Cas9 has
been used to develop a sterile salmon through
knockout of the dead end (dnd) gene; the aim being
to prevent hybridization and potential gene introgres-
sion of escapee farmed salmon into wild populations
(Güralp et al. 2020; Wargelius et al. 2016). The
technique has also been used to understand the role of
the elov-2 gene in omega-3 production of Atlantic
salmon (Datsomor et al. 2019b). Other examples
include use of CRISPR/Cas9 in immunological studies
on different salmon species (Dehler et al. 2016, 2019;
Gratacap et al. 2019b) and as a research tool (Dehler
et al. 2016, 2019; Gratacap et al. 2019a, b; Chen et al.
2018; Cleveland et al. 2018).
Apart from the CRISPR/Cas9-modified tilapia,
CRISPR/Cas9 is being used to modify several other
traits in different species (Gratacap et al. 2019b; Zhu
and Ge 2018; Blix et al. 2021). The most widely edited
species are Nile tilapia, Zebra fish (Danio rerio) and
Medaka (Orizyas latipes) (see Reviews by Gratacap
et al. 2019b; Zhu and Ge 2018; Blix et al. 2021).
Specific reproduction traits targeted for editing in Nile
tilapia are sterility (eg. Jin et al. 2020), fertility (eg.
Chen et al. 2017; Yan et al. 2019) and sex determi-
nation (eg. Li et al. 2015; Liu et al. 2020). In addition,
editing of non-coding sequences to induce deletion of
large fragments of microRNA and 3untranslated
regions (3UTRs) has been conducted in tilapia (Li
et al. 2019); this is one out of few studies using finfish
species to attempt homology directed repair (HDR).
Others are in Atlantic salmon targeting pigmentation
(Straume et al. 2020) and sterility (Straume et al.
2021); and in farmed carp (Labeo rohita) (Chakrapani
et al. 2016) and channel catfish (Ictalurus punctatus)
(Elaswad et al. 2018a, b) targeting disease resistance
and insertion of transgenes (Simora et al. 2020).
Further application of CRISPR/Cas in other fish
species of commercial importance (for foods and
ornamental value) include editing of disease resistance
genes in grass carp (Ctenopharyngdon idella) (Ma
et al. 2018), farmed carp (Chakrapani et al. 2016), and
channel catfish (Elaswad and Dunham 2017; Elaswad
et al. 2018a, b). Editing of growth-related genes has
been conducted in common carp (Zhong et al. 2016),
channel catfish (Khalil et al. 2017), tiger puffer fish
(Takifugu rubripes), red sea bream (Pagrus major)
(Kishimoto et al. 2018, 2019) and in olive flounder
(Paralichthys olivaceus) (eg. Kim et al. 2019). In
addition, studies in different species targeting pig-
mentation as a commercial trait as well as a visual
tracer for research purposes have been reported (eg.
Chen et al. 2019; Edvardsen et al. 2014; Liu et al.
123
Transgenic Res
2019; Mandal et al. 2020; Wargelius et al. 2016; Xu
et al. 2019). In this study we focus on fish of
commercial importance with special emphasis on
salmon.
Despite the notable advances in application of
CRISPR/Cas in fish aquaculture, risk assessment (RA)
and regulatory approval as well as public and
consumer acceptance are key to commercialization
of the products of CRISPR (and other GE) technology.
Apart from the two commercialized fish—the trans-
genic AAS and the GE tilapia, several others are at
advanced stages of development, but regulatory and
RA frameworks as well as requisite data and experi-
ence for evaluating the safety of these products are
lacking. Consumer confidence and public acceptance
of the new technology are predicated on ability of
respective authorities to demonstrate robust, transpar-
ent and trustworthy regulatory and RA oversights.
Several authorities have begun revising their frame-
works to bring them in tandem with the envisaged
challenges that will necessarily arise from GE prod-
ucts. These have mainly focused on plant GE products
(Eckerstorfer et al. 2019b) with the result that revision
and update of frameworks for GE fish and other
aquacultural products lags (Larson et al. 2013; Euro-
pean Commission/SWD 2021). Here we highlight
some of the most important issues that bedevil use of
existing regulatory and RA frameworks for GE fish
with focus on CRISPR/Cas-edited fish, and suggest
research strategies that can ameliorate these. We also
discuss some of the important technical challenges as
well as pertinent issues surrounding sustainability and
public acceptance of the technology in fish
aquaculture.
Genome editing (GE) techniques
In the current political debate and regulatory literature
(and in this study), the term GE (also termed new
genetic modification -nGM) is used to denote the
emerging molecular biology techniques that make
targeted (inserting, deleting or substituting) changes to
an organisms DNA. The relatively older non-targeted
molecular biology tools for genetic modification are
termed GM techniques (classical or old GM tech-
niques are also used in the literature). Techniques that
belong to GE are CRISPR/Cas [including all the
variants that are being developed; the most advanced
being the CRISPR/Cas9 variant (Larson et al. 2013;
McDonald et al. 2016; Qi et al. 2013)], zinc finger
nuclease (ZFN), transcription activator-like effector
nuclease (TALEN), oligonucleotide directed mutage-
nesis (ODM), and meganucleases. These GE tech-
niques are termed site-directed nucleases (SDN)
because, unlike the old GM techniques, SDNs are
directed to a specific part of the genome where they
induce targeted and precise mutations (EFSA 2012).
The ODM and meganuclease (meganuclease is also an
SDN, but is relatively very cumbersome to use (Silva
et al. 2011)) have been phased out by the less
cumbersome SDNs comprising CRISPR/Cas, ZFN
and TALEN, of which CRISPR/Cas is the most
popular. The European Food Saftey Authourity
(EFSA) (EFSA 2012) has defined three categories of
SDNs viz: SDN-1, SDN-2 and SDN-3. In SDN-1, only
SDNs are stably or transiently introduced aimed at
generating random mutations at the target site, thus,
repair of damaged host DNA is by endogenous
nucleotides. SDN-2 uses small non-protein coding
homologous repair DNA (donor DNA) to achieve
specific nucleotide sequence changes by HDR. In
SDN-3 a large stretch of protein coding donor DNA
(up to several kilobases) is targeted for insertion, also
by HDR, at a predefined genomic locus (EFSA 2012).
Presently, CRISPR/Cas is the most popular SDN
because of its relative ease of use, low cost and high
efficiency (Wang et al. 2016). The most advanced
variant of CRISPR/Cas, CRISPR/Cas9, makes dou-
ble-strand cuts at specific target sites on the DNA
inducing a repair of the cut sites by the cells
endogenous DNA repair mechanisms: HDR and
non-homologous end joining (NHEJ) (Jiang and
Doudna 2017). The NHEJ is error prone, thus the
repair process often leads to alteration of the DNA
sequence in the form of deletion, insertion or substi-
tution of nucleotides (Jiang and Doudna 2017). Such
alterations can render the target gene non-functional,
i.e., knocked out (KO), which is desirable in gene
knockout applications. Exogenous DNA sequences
can be used as templates via the HDR repair mech-
anism to introduce donor nucleotide sequences
through substitution and insertions at target sites
(Jiang and Doudna 2017). Although HDR is not the
prefered DNA repair mechanism, simultaneous addi-
tion of homologous DNA sequences during the DNA
repair of double strand breaks (DSBs) can shift the
balance from NHEJ to HDR (Jiang and Doudna 2017).
The introduction at the target site of a single strand
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break rather than a DSB can also shift the balance in
favor of HDR (Jiang and Doudna 2017). Thus, these
strategies are being used to make undirected nucleo-
tide changes (SDN-1) or directed nucleotide changes
(SDN-2 and SDN-3) at targeted gene sites. The SDN-3
differs from SDN-2 in that the former leads to the
insertion of protein coding transgene(s) while the
latter inserts small non-protein coding sequences, e.g.,
regulatory sequences (EFSA 2012).
Changes in the genetic material of an organism can
give rise to perturbations in the well-orchestrated gene
expression both in the vicinity of the change or at loci
distant from the target sites. In theory, SDN-3, which
creates a transgenic organism can lead to greater
irregularities in the genome compared to SDN-1 and
SDN-2 (Agapito-Tenfen et al. 2018; EFSA 2012).
This has resulted in some regulatory authorities to
propose less stringent pathways to the RA of products
arising from SDN-1 and SDN-2, especially for SDN-1
involving small nucleotide changes, e.g. a point
mutation, that can also be achieved in nature (Euro-
pean Commission/SWD 2021). Nonetheless, it is
pertinent to ascertain that all GE products are safe
for the environment and/or as food/feed before
approval for commercialization, although the RA
challenges of the technique will depend on type of
modification, i.e., whether SDN-1, SDN-2 or SDN-3.
Limitations in the use of CRISPR/Cas in fish
aquaculture
Technical challenges
The advantages of CRISPR/Cas notwithstanding,
realization of the techniques full potentials in fish
aquaculture is hindered by some technical challenges
which are summarized from both the genetic and the
application perspectives:
Genetic perspective
(1) Aquatic genomic resource is still limited,
although the most important aquatic species
have been sequenced (Wargelius 2019). Gen-
ome editing requires clear and robust knowl-
edge of genetic background, in practical terms,
genomic sequences. Owing to the development
of sequencing technology and declining
sequencing cost, the genomes of over 70 aquatic
fish species have been deciphered since fugu—
the first sequenced aquatic species in 2002
(Aparicio et al. 2002), which is a substantial
achievement during the past decades. However,
they are still too few compared with the total
number of aquaculture species, which according
to FAO, is over 600 (FAO 2020). Moreover and
for non-model species such as the Atlantic
salmon, the sequenced genomes are poorly
annotated (Sundaram et al. 2017), thus,
CRISPR/Cas application in aquaculture will
benefit from further refinement, e.g. removal of
duplications in annotations from the available
genomic sequences.
(2) Trait-related genes need clarification. Since
genetic dissection in aquatic organisms lags
behind those of human and plants, trait-related
genes need to be determined. In other word,
which gene should be targeted? The process of
identification of target genes which is via
quantitative trait locus (QTL) mapping or
marker assistance, is usually a long process.
Although resequencing technology now facili-
tates the process, identification and confirmation
of polygenic determined trait still hinders pre-
cise identification of candidate genes.
(3) Duplication event in fish. Amongst aquatic
organisms, fish represents the category with
the most abundant species. However, teleost
experienced a teleost-specific whole genome
duplication (TS-WGD) (Glasauer and Neuhauss
2014). In salmon this issue is expanded with the
salmon-specific 4th round (Ss4R) (Glasauer and
Neuhauss 2014). The manner in which the
duplication hinders the editing efficiency of GE
techniques in, e.g., finfish has been discussed
(Chen et al. 2018; Cleveland et al. 2018;
Datsomor et al. 2019b; Gratacap et al. 2019a),
and comparison between genes with various
copies in the genome could be performed to
elucidate this issue.
Application perspective
(1) Egg membrane makes success rate of microin-
jection low for oviparous fish. For
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ovoviviparous fishes, there is no established
gene editing platform at present.
(2) The detection of off-target effect in model
organisms focuses more on knockout efficiency
(i.e. via the NHEJ/SDN-1 approach) in order to
optimize CRISPR/Cas design. While as food
resource, off-target effect in aquatic organisms
should also focus on the impact of addition of
new genes through transgenesis or cisgenesis
(i.e. via HDR/SDN-3 approach). This requires
more careful assessment, including both off-
target in the genome and potential risk related to
food quality or safety. Options for prevention or
detection of off-target mutations are careful
design of the annealing gRNA by comparison to
existing genome assemblies, or by screening for
unexpected mutations post-editing. Regarding
the latter, natural genetic variation in different
families and strains leaves detection post-edit-
ing complicated (Blix et al. 2021).
(3) No standard protocol exists due to various
features of aquatic organisms, which requires
species-specific design such as needle type,
injection dosage, etc. Due to lack of established
cell lines and small size of egg and embryo in
crustacea and molluscs, successful GE has been
reported only in Crepidula fornicate, Exopalae-
mon carinicauda, and Crassostrea gigas (Gui
et al. 2016; Perry and Henry 2015; Yu et al.
2019).
Others
(1) In many aquatic species, the generation interval
is rather long, which makes the acquisition of
mutated homozygous individuals rather time-
consuming during GE process. However, it is a
possible solution to combine GE with surrogacy
technology (Jin et al. 2021).
(2) Sterile organism is especilly favored during
commercial application due to these two rea-
sons: protection of intellectual property and the
avoidance of GE individuals’ invasion into wild
population. However, this would require
increased effort at keeping heterozygous indi-
viduals for population maintenance. Recently,
Güralp and colleagues (Güralp et al. 2020)
reported a method that could rescue the germ
cell in dnd crispant-embryos of Atlantic salmon,
which could then produce sterile offspring
(germ-cell free) through the genetically sterile
broodstock.
Possible solutions to these challenges
Genetic perspective
(1) The decreasing cost of sequencing (less than
$10/sample) will see more aquatic genomes
being deciphered in future, which will lay the
necessary genomic foundation for future GE
events.
(2) Increasing refinements in QTL and genetic and
molecular biology methods (e.g. QTL mapping,
comparative genomics, and pooled CRISPR
screens) will result in more trait-related genes
being identified (details reviewed by Houston
et al. 2020). On the other hand, specific genes
that confer favourable traits across species and
lines should be focused as promising candidates.
For example, the current study (e.g. https://
www.fhf.no/prosjekter/prosjektbasen/901631/)
on the transfer of resistance to sea lice from
Pacific salmon species to Atlantic salmon
(Barrett et al. 2020) might result in de novo
idenfication of resistant genes.
(3) In terms of the trait involved in several genes
(quantitative trait), generating multi-gene
knockout mutants simultaneously by CRISPR/
Cas will provide the possibility of inducing the
desired phenotype.
Technically great success has been achieved in some
fish species with obtaining various GE lines, espe-
cially Atlantic salmon and tilapia. These species
should be employed as ‘‘aquaculture models’’ to
initiate the optimization of aquatic CRISPR/Cas
protocols and physiological assessment of potential
off-target effects (for food quality and safety). The
derivable knowledge from this approach is transfer-
able to other fish species.
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How suitable are the current regulatory and risk
assessment frameworks for challenges arising
from CRISPR-modified GE fish?
Regulatory and risk assessment frameworks
Many countries have developed regulatory frame-
works to guide approval for environmental release
and/or use of GM organisms as food, feed and fiber
(Ishii and Araki 2017; Turnbull et al. 2021). The main
element in these regulatory frameworks is a manda-
tory RA of human safety and environmental risks. The
regulatory trigger is based on how a GMO is defined,
which has some differences among different regula-
tory authorities, whereby some focus on the process by
which the product is modified while others focus on
the novelty of the final product (Eckerstorfer et al.
2019b; Turnbull et al. 2021). In the EUs Directive
2001/18/EC (EU-Directive 2001), a GMO is defined
as ‘‘the genetic material of the organism has been
altered in a way that does not occur naturally by
mating and/or natural recombination’’. The Directive
mandates that all GM animals and crops be subjected
to regulatory review via stipulated detailed proce-
dures. The European Commission (EC) is the regula-
tory authority in the EU, although at the Pan-
European-level, each member country has respective
regulatory body that liaises with the EC.
Different regulatory authorities throughout the
world including the EU, Argentina, Brazil, Australia,
New Zealand, Canada, USA and Norway have begun
discussions on how to regulate products arising from
the new GE techniques (Eckerstorfer et al. 2019b;
Turnbull et al. 2021). Overviews of regulatory frame-
works have been published by Ishii and Araki, 2017
and Turnbull et al. 2021. Box 1 provides the present
state of discussions in Norway, China and the United
Nations Convention on Biodiversity. China is at
present the leading country on publications on GE in
fish aquaculture, while the most publications on GE of
salmon is from Norway (Blix et al., 2021).
The main issue is: should organisms modified by
GE be regulated using the existing GMO regulatory
frameworks? The European Court of Justice (ECJ) in
its ruling of 2018 (Court of Justice of the European
Union 2018) made it clear that the established EUs
exemption of mutagenesis is only relevant for organ-
isms obtained through methods of mutagenesis that
have been conventionally used in the past and have a
history of safe use. The GE techniques, including
CRISPR/Cas, are not covered under this exemption
given that they do not yet have any history of safe use.
This implies that all applications for approval of GE
products will trigger the current GMO regulatory
frameworks in the EU. However, this decision has
been contested: while waiting for the decision of the
ECJ, Sweden used its national legislation to exempt
products of SDN-1 from regulation while regulating
products of SDN-3 as GMOs (Eriksson 2018). Sim-
ilarly, in Argentina the SDN-1 CRISPR/Cas9-modi-
fied tilapia is exempted from regulation (Evans 2018).
More amendments to the regulatory frameworks are
expected as better understanding and insights are
obtained regarding the GE techniques.
The present regulatory discussions on GE products
by various authorities (Eckerstorfer et al. 2019b;
Turnbull et al. 2021) is expected to result in the
revision of the existing RA guidelines. For example,
Canada recently initiated the review of its RA
requirements for products arising from GE techniques
(Eckerstorfer et al. 2019b); the European Food Safety
Authority (EFSA) has been mandated by the EU to
provide an opinion on the type of risks associated with
plants produced through SDN-1 and SDN-2
approaches (EFSA 2019), but has not been mandated
for an opinion or revision of guidelines regarding RA
of GE animals includingGE fish. The need for revision
of the existing RA guidelines has also been empha-
sized in recent study mandated by the European
Commission on the status of new genomic techniques
under Union law and considering the ECJs 2018
ruling (European Commission/SWD 2021).
At present specific RA frameworks and guidelines
do not exist for organisms and products developed by
GE technologies including CRISPR/Cas. Thus, for
assessment of GE products, risk assessors currently
adopt/tailor the frameworks originally developed for
GMOs (Agapito-Tenfen et al. 2018); see Box 2 for
definitions of terms and concepts used in RA. For GE
fish, the current practice is to use the general RA
guidelines developed for GM animals. In recognition
of the problem, the United Nations (UN), through the
Conference of the Parties serving as the meeting of the
Parties to the Cartagena Protocol on Biosafety (COP-
MOP), recently mandated a process towards develop-
ing guidance materials on RA for GE fish (Sweet
2019). However, in terms of living modified fish, the
guidelines will not be adapted as the CBD has decided
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not to develop additional guidance materials on RA.
This implies that any application needs to follow the
current guidelines. The Cartagena Protocol on Bio-
safety (CPB) describes five main RA steps: an
identification of any novel genotypic and phenotypic
characteristics, an evaluation of the likelihood of
adverse effects, an evaluation of the consequences
should these adverse effects be realized, an estimation
of the overall risk, and a recommendation as to
whether or not the identified risks are acceptable or
manageable (Cartagena Protocol 2000).
Challenges and limitations of the current RA
guidelines
Apart from the CRISPR/Cas9-edited tilapia, there are
no other commercial GE fish species, therefore,
experience as well as guidance for specific RA of fish
modified by GE techniques, including CRISPR do not
exist (CBD/SBSTTA 2020; Sweet 2019). Even for
plants (and livestock to a lesser extent) which have
greater number of commercialized CRISPR/Cas-
edited products, there exists no specific and harmo-
nized guidelines tailored for their RA, such that in the
Box 1 Examples of GMO regulatory frameworks
GMO regulation in China
In China, the testing, production and marketing of GMOs are subject to government approval. The regulation of GMOs is
primarily provided by the agricultural GMO regulations enacted by the State Council in 2001 and relevant administrative
rules. Agricultural GMO regulations regulate not only crops, but also animals, microorganisms and products derived from
these sources. Foreign companies that export GMOs, including GMOs as raw materials, to the People Republic of China, must
apply to the Ministry of Agriculture and obtain GMO Safety Certificates – see English translation at: https://www.loc.gov/law/
help/restrictions-on-gmos/china.php and https://link.springer.com/chapter/10.1007/978-981-13-8102-7_15
At the moment, there is no separate regulation of products of GE in China since it is still under debate whether products of GE
techniques belong to GM category, but the general rules for GM organism applies, which can be summarized as ‘ensuring
safety, independent innovation, active research and careful promotion‘. GM soybean and cotton have been imported and
widely cultivated in China. Nevertheless, indigenous developed GM crop is limited, although safety certifications of three
major GM crops (two rice and one maize variety) were approved by Ministry of Agriculture and Rural Affairs since 2014 and
renewed in 2019 (valid for five-year duration) (Ministry of Agriculture and Rural Affairs 2019)
Norway
The Norwegian Gene Technology Act (NGTA) of 1993 (Norwegian Gene Technology Act 1993) requires consideration of
health and environmental safety, ethical aspects, social utility and contribution to sustainability of GMOs. The first paragraph
states: ‘‘The purpose of this Act is to ensure that the production and use of genetically modified organisms and the production
of cloned animals take place in an ethically justifiable and socially acceptable manner, in accordance with the principle of
sustainable development and without adverse effects on health and the environment’’ (NGTA 1993 §1) (Norwegian Gene
Technology Act 1993). More specifically, the Act lays down that GMOs may only be approved when there is no risk of
adverse effects on human or animal health or the environment, and that ‘‘considerable weight shall be given to whether the
deliberate release will be of benefit to society and is likely to promote sustainable development’’ (NGTA 1993 §10,2)
Norway is not a part of the EU, but as a member of the European Economic Area (EEA), the EU legislations -Directive 2001/18/
EC, is applicable. Consequently, an approval of a GMO in EU automatically leads to an approval in Norway, unless Norway
specifically prohibits importation of the product. The Norwegian Biotechnology Advisory Board (NBAB) has suggested a
relaxed regulation depending on the level of GE modification, i.e. SDN-1, SDN-2 or SDN-3. An expert committee has been
appointed to elaborate on this among other issues; the final report will be published in 2022
CBD-CPB
The Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity (CBD) is an international agreement that
aims to ensure the safe handling, transport and use of living modified organisms LMOs (LMO is used in the CP in place of
GMO). The CP has been ratified by 173 countries (Cartagena Protocol 2000). The protocol adopts the precautionary principle
and has an established biosafety clearing house to facilitate exchange of information. Both the EU, Norway and China have
ratified the protocol, while some of the major producers of GMOs including the USA, Argentina, Canada have not ratified the
protocol. At present, GE is discussed as a topic in synthetic biology under the CBD, and hence not directly under the CP. An
expert group -the Ad Hoc Technical Expert Group (AHTEG) has been mandated to deliberate on this, and it is expected that
the outcome of the deliberation will be presented in the next meeting of the parties to the CBD in the third quarter of 2021 in
ChinaArgentina, Canada have not ratified the protocol. At present, GE is discussed as a topic in synthetic biology under the
CBD, and hence not directly under the CP. An expert group -the Ad Hoc Technical Expert Group (AHTEG) has been
mandatedestablished to deliberate on this, and it is expected that the outcome of the deliberation will be presented in the next
meeting of the parties to the CBD in the third quarter of 2021 in China
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EU for example, the current GMO guidelines, which
recognizes all GE products as GMOs are used (EFSA
2020). The situation is the same in Canada, the USA
and China which are some of the leading countries in
the production and export of both GE and GM
products (Turnbull et al. 2021). Several of the
aquaculture end products (including fish) of
CRISPR/Cas [for fish and aquaculture products cur-
rently being developed using CRISPR/Cas technique,
see reviews and book chapter by (Dunham and Su
2020; Gratacap et al. 2019b; Wargelius 2019)] will at
some point be evaluated for commercialization. This
underscores the need to evaluate the suitability of the
existing RA frameworks. The existing RA frame-
works, which are tailored for products of the classical
GM techniques are not adequate for products arising
from the new GE techniques, given that RA issues
related to the latter are different (Benessia 2015;
Dunham and Su 2020; Eckerstorfer et al. 2019a;
Kawall 2020; Lema 2021; Turnbull et al. 2021). The
main difference is that GE technologies, in particular
CRISPR/Cas, has the potential for numerous new
genetic possibilities due to its efficiency, robustness
and ease (Agapito-Tenfen et al. 2018; Eckerstorfer
et al. 2019a; Kawall 2019), and can make greater
genetic intrusions with farther reaching consequences.
Further, there is insufficient prior knowledge on new
traits being developed in fish and other aquaculture
products using CRISPR/Cas, many of which may be
difficult (or impossible) to derive comparable infor-
mation on their activities from non-modified near
isogenic comparators. Added to these is that unin-
tended effects of CRISPR/Cas technology are essen-
tially different from those of the GM techniques. Some
of the unintended effects associated with the CRISPR/
Cas technology, which are relevant for RA of GE fish
include: unintended changes at genome locations
different from the target site, i.e., off-target mutations;
unintended changes at the target site associated with
the specific CRISPR/Cas modification process (i.e.
unintended on-target site mutations) (Kosicki et al.
2018). Similar to the effects of GM in plants, these
unintended effects can lead to undesired pleiotropic
effects such as abnormal expression of endogenous
genes due to integration of non-endogenous sequences
in sites not intended for modification (Ladics et al.
2015; Latham et al. 2006; SAM 2017). Undesired
pleiotropic effects can potentially also occur even with
Box 2 Risk Assessment: definitions of terms & concepts
Risk: the likelihood of an adverse event happening, and the seriousness of the harm represented by the events occurrence
(Raybould 2020). Risk has also been defined as hazard multiplied by exposure‘ (Dorne and Fink-Gremmels 2013). The
decision maker, i.e., the regulatory authority of a country decides the level of risk allowable for a given GMO event
Risk assessment: the process of determining the occurrence, frequency and consequences of harmful events
Hazard: is an event or substance that can have harmful effect
Harm: an event or substance that can have adverse effect on the goals that the regulatory authority wishes to protect, such as
wild species, biodiversity, human and animal health, etc. For an illustration of pathway to harm, see (Raybould 2020)
Aims of risk assessments: (i) Environmental risk assessment (ERA): aims to identify potential impacts on the valued
components (protection goals) of the environment, and to estimate the probability and magnitude of these impacts if a GMO is
accidentally or intentionally introduced into the environment
(ii) Food safety risk assessment: aims to identify substances in the GMO that may be hazardous (such as toxicity or
allergenicity) to human or animal health
Risk assessment methodologies:
(a) Based on statistical nature of output:
(i) Qualitative: produces nominal (e.g. list of endangered species) or ordinal (e.g. low, medium, high) outputs;
(ii) Semi-quantitative: produces interval variables (e.g. 1–5, 5–50,[ 50) as outputs;
(iii) Quantitative: produces continuous risk estimates, which may or may not be grouped into categories
(b) Based on period of occurrence of event:
(i) Retrospective: attempts to identify the causes and characteristics of harmful events that have already occurred;
(ii) Predictive: seeks to predict the likelihood and consequence of a harmful effect that has not yet occurred. See (Kapuscinski
2007) for a comprehensive discussion on types of risk assessment
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perfectly targeted editing of the desired gene, which
underpins the need for phenotypic comparison of
edited product with the non-edited isogenic counter-
part during RA. Further, integration of vector back-
bone into cells (Braatz et al. 2017); effects of methods
used to facilitate uptake of the genetic molecule
(Mehrotra and Goyal 2012) (Cas/sgRNA in the case of
CRISPR/Cas) such as microinjection, electroporation
and lipofection; effects of specific RNA or ribonucle-
oprotein complexes (Latham et al. 2006); have all
been shown to cause abnormal expressions of endoge-
nous genes. The impacts of these on both environ-
mental risk assessment (ERA) and RA for food safety,
as elaborated below, is varied and depends on the GE
fish species, respective trait, type of modification
(SDN-1, SDN-2 or SDN-3) and the receiving
environment.
ERA
The cardinal ERA issues of GE fish are related to
release (both intentional and inadvertent) in the
environment because such escapees can; a) hybridize
with the wild population and can, for SDN-3, lead to
dispersion of transgenes (Devlin et al. 2010; Oke et al.
2013; Wringe et al. 2018), and/or b) interfere with
existing biodiversity. The environmental risks associ-
ated with escapees are (a) changes to the population
genetics of closely related species in the receiving
environment via mating and alteration to genetic
biodiversity (Hayes 2007; Kapuscinski 2007); (b) dis-
turbance in ecological balance via alteration of the
food web and destruction of habitat. However, this
pertains less to GE fish in inland and contained
aquaculture facilities, and more to GE fish in aqua-
culture systems located in waterways or marine/-
coastal environments where escapee farmed fish and
inadvertent introduction of farmed fish into the
environment are possible. Physical and biocontain-
ment barriers are mandatory conditions for ERA of GE
fish (Devos et al. 2019; Kapuscinski 2007), neverthe-
less, these two interventions are not guaranteed. For
example, the biocontainment strategy through poly-
ploidy (the induction of 3 or more chromosomes in fish
eggs to reduce their fertility), which was employed as
part of the transgenesis of the commercialized AAS
(Devlin et al. 2010) is leaky because a small percent-
age remains as diploid fertile fish expressing growth
hormone, such that there could be some fertile
individuals among escapee salmon (Benfey and Sut-
terlin 1984). Besides, generating polyploidy in fish is
also an animal welfare issue. Similarly, physical
containment is not foolproof because escapee farmed
Atlantic salmon have been reported at wild salmon
spawning grounds (Bergan et al. 1991; Gausen and
Moen 1991; Jensen et al. 2013). This has led to
criticism on the extent of the physical and biocontain-
ment conditions of the ERA that was conducted for the
commercialized AAS (Benessia 2015; Sweet 2019)
especially given the difficulty of providing or predict-
ing environmental impacts of release of GE fish.
Unfortunately, no information on ERA is publicly
available for the commercialized GE tilapia. The
challenge to ERA is whether the effects of hybridiza-
tion and transgene introgression of the released GE
fish can affect overall fitness including survival,
migration, spawning, reproduction, etc., of the wild
population. The sterile GE salmon by the Wargelius
group (Wargelius et al. 2016; Güralp et al. 2020), as a
proof of prinicple, can prevent hybridization from
SDN-1 and SDN-2 fish, and transgene introgression
from SDN-3 fish via interbeeding between a released
GE fish and wild population, but the impacts of such
modification on overall fitness of the fish under natural
conditions have not been conducted. Unfortunately,
the natural and environmental conditions that influ-
ence these factors cannot be studied under controlled
laboratory conditions (Leggatt et al. 2017; Sundstrom
et al. 2007). However, the concept of combining
sterility trait and other traits in the same GE fish
increases the prospect of avoiding hybridization with
wild relatives and controlling transgene introgression
by escapee GE fish from open water commercial fish
farms.
RA for food safety
The aim of RA for food safety is to ensure that the
process of modification as well as the effects (both
intended and unintended) have not resulted in toxicity,
allergenicity and/or decreased food quality (i.e. unde-
sirable biochemical composition of the edible tissues)
of the modified fish (EFSA 2013). Effects of the
CRISPR/Cas modification process, unintended effects
as well as intended new traits can affect the fitness and
hence the quality of the actual edited fish. Currently,
systematic studies have not been conducted on the
impact of unintended effects of GM (or CRISPR/Cas)
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on the quality/safety of edible tissues of GE fish (or
any GM or GE modified animal), although unintended
changes have been reported to alter disease resistance,
foraging behavior, gene expression, reproduction and
life-history timing (Abrahams and Sutterlin 1999;
Devlin et al. 2015). Extrapolations from specific
examples of past experiences with GM and genetic
engineering technologies can help deduce potential
impacts of CRISPR/Cas on the quality of edited fish
for RA purposes. For example, biochemical analyses
of the components (carbohydrates, proteins, total fats,
vitamins andminerals) of the edible tissues of the AAS
show no significant variations compared with the
unmodified counterpart, except a slight variation in the
concentration of vitamin B6 (Benessia 2015). The
mRNA expression levels of the following proteins
were reported as increased in a growth-modified
transgenic amago salmon (Oncorhynchus masou):
haeme oxygenase; leukocyte cell-derived chemotaxin;
a-trypsin inhibitors; iron metabolic proteins; and
proteins of the reproductive system, while the expres-
sions of lectin, D-6-desaturase, apolipoprotein and
pentraxin were reduced (Mori et al. 2007). In a
transgenic coho salmon, glutathione levels; glu-
tathione reductase and gamma-glutamiltranspeptidase
activities were increased by growth hormone modifi-
cation (Leggatt et al. 2007). A CRISPR/Cas9-based
ablation of elovl2 gene (an essential gene in synthesis
of long chain polyunsaturated fatty acids LC-PUFA),
resulted in the accumulation of different polyunsatu-
rated fatty acids, and up-regulation of several genes
involved in fatty acid metabolism in Atlantic salmon
(Datsomor et al. 2019b). The extent to which these can
impact the quality of edible tissues of the GE fish is
unknown. The AAS was also evaluated for allergenic-
ity via dermal contact (Leggatt 2013) according to
present RA standard procedures. However, the impact
of the intended increased growth hormone on the
edible tissues and its possible health implications was
not conducted, neither were the direct and indirect
impacts on the entire cellular metabolic network
performed (Benessia 2015; Van Eenennaam 2011). It
is questionable whether the current standard molecular
characterization, toxicity and allergenic studies for
characterization of GM food safety is sufficient for
products of CRISPR/Cas technology. It has been
argued (Abrahams and Sutterlin 1999; Devlin et al.
2015) that GM products should also be evaluated for
anti-nutrients or lowered nutrients, this may also be
relevant for GE products. Others (Kawall 2020;
Agapito-Tenfen et al. 2018) have also argued that in
addition to standard molecular characterization, omics
evaluation of GE products, especially with regard to
unintended changes, will provide relevant additional
data for robust RAs. Nonetheless, it is clear that
determining whether these unintended changes have
(or are associated) with any harmful effects is complex
and presents a challenge to the present RA
frameworks.
Issue of sustainability
Most GMO regulatory frameworks mainly include
safety questions on guidelines for health and ERA. In
addition to this, it is important, in the case of GE, to
acknowledge the social dimensions of how natural
sciences use nature (Palsson et al. 2013). Food has an
impact on human lives that is of both cultural and
biological importance, and it is therefore not sufficient
to consider only measurable risk. Food is also about
traditions and ways of life (Myskja and Myhr 2020).
Several questions of risk, e.g., future effects of
horizontal gene transfer, are not possible to answer
in present terms. These become questions about what
human changing nature might lead to, and whether this
is something that society is willing to accept. Hence,
the ‘‘[…] blurry line between risk and sustainability
demonstrates the significance of including non-safety
issues in order to make a decision that is socially
acceptable’’ (Myskja and Myhr 2020).
There is no common practice of evaluating non-
safety criteria of GMOs, even though several countries
have implemented such measures (Myskja and Myhr
2020). In Norway, GMO regulation frameworks
include both environmental/ecological, societal and
economic dimensions, through including non-safety
criteria—contribution to sustainable development,
ethical justifiability and societal utility in the evalu-
ation process of GMOs (Box 1). The criterion of
contribution to sustainable development is interesting
considering the frequent use of this term, e.g. in global
and national aquaculture strategies and reports. How-
ever, a framework operationalizing contribution to
sustainable development at present has only been
developed for GM plants (NBAB 2009, 2011, 2014).
An alternative to developing a framework is to make
requirements for certifications under international
certification schemes; an example for GE fish could
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be certification under the Aquaculture Stewardship
Council (ASC).
Consumer perception and acceptability
The new possibilities of GE, especially CRISPR/Cas,
as stated above, call for updated regulatory and RA
frameworks and guidelines. Likewise, they demand a
new public discussion on the application of the
technology in food production amongst other areas
of use. Historically, GM has been associated with
controversy. The aspects raised in public discourses
are connected to animal moral status, the argument of
whether genetic engineering is natural or unnatural,
the percieved risks and benefits of genetically engi-
neered animals to health and the environment, the
purpose of the application, the methods being used and
the motivation of the researchers. And finally the
species itself—its intrinsic value, species boundaries
and animal ethics (Van Eenennam and Young 2018).
These aspects may be important for public and market
acceptance of GE products.
Scientific knowledge and research-needs on risk
assessment, sustainability and consumer
perception of CRISPR-modified GE fish
Available studies
The data requirements for RA of CRISPR/Cas-mod-
ified GE fish, while being similar to fish modified by
other GM techniques, differ with respect to the unique
process of CRISPR/Cas modification. Obtaining data
relevant for RA of CRISPR-modified GE fish is at its
infancy: no information is publicly available even for
the only commercialized CRISPR/Cas9-modified GE
fish -the GE tilapia. However, some information exist
on ERA, RA of food safety, sustainability and
public/consumer perception for GM fish which can
be extrapolated, albeit only to a certain degree, to GE
fish.
ERA
Some ERA-relevant studies on transgenic fish have
been conducted but these relied mainly on labora-
tory/confined field (Devlin 2007) and modelling
(Ahrens and Devlin 2011; Li 2014) studies and not
on field studies. In the laboratory/confined field
studies, the approach is the application of semi-natural
conditions and use of surrogate models in nature
(Devlin et al. 2006). EcoPath and Ecosim modelling
have been applied in predicting effects of releases of
growth hormone transgenic salmon (Ahrens and
Devlin 2011; Li 2014). For example, computer-based
modelling simulations found that presence of trans-
gene can potentially shift genetic backgrounds and
phenotypes of both GM and non-GM fish away from
the naturally selected optima (Ahrens and Devlin
2011). However, it is not practicable to obtain data that
accurately depict pathway to harm of GM fish when
released into natural conditions (Devlin et al. 2015;
Sundstrom et al. 2007). This has raised uncertainties as
to the extent data generated from these studies can be
used in ERA, such as uncertainties related to extrap-
olating results from confined tests to natural ecosys-
tems, pleiotropic effects and phenotypic trade-offs
between traits and genotype-by-environment interac-
tions (Benessia 2015; Devlin 2007).
RA of food safety
There is at present no systematic data available on the
pysiopathology of GE fish. Even for the most studied
Salmonidae subfamily, different methodologies and
research objectives have been used. For example, in
the widely studied growth hormone-expressing trans-
genic coho salmon, amago salmon and Atlantic
salmon, few studies on biochemical alterations caused
by deregulation of growth hormone expression are
available (Leggatt et al. 2007; Mori et al. 2007). The
most available comprehensive study is the biochem-
ical characterization on AAS by the producer—
Aquabounty (AquaBounty Technologies Inc. 2010;
Benessia 2015), but no independent systematic studies
on AAS have been reported in the published literature.
Studies on safety of GE fish for human consumption
should not be limited to the direct effect of the
transgene (VMAC 2010) for SDN-3 fish, nor allergens
(Van Eenennaam 2011), but also extended to the direct
and indirect effects on the entire metabolic network
(for SDN-1, 2 and 3). In this regard, the application of
new and robust molecular biology analytical tech-
niques such as omics (in particular proteomics and
metabolomics) can be useful (Agapito-Tenfen et al.
2018; Eckerstorfer et al. 2019a; Kawall 2020). For
example, a research group (Datsomor et al. 2019b)
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recently used lipidomic and transcriptomic analyses to
characterize the impact of a CRISPR/Cas9-elovl2
knockout event on lipid biosynthetic pathway.
Sustainability
Many countries have agreed on Agenda 2030 and
committed to the United Nations’ 17 global sustain-
able development goals (SDGs) for a better future (UN
2015). The overarching goal by this commitment is to
make possible dignified human life while at the same
time permanently and on a sustained basis protect
natural conditions of life. The three key parts of
sustainability is included within the SDGs: economy,
society and the environment. These could be used as
guidance for what measures within sustainable devel-
opment should be assessed. The scope of SDGs is wide
and includes 169 specific targets (UN 2015), which are
important and internationally accepted goals. Adopt-
ing these widely accepted goals could also ease
defending the inclusion of non-safety issues interna-
tionally. In addition to the UN SDGs, both protection
of biodiversity, ecosystems and development of sus-
tainable food production systems are part of A
European Green Deal (European Commission Grean
Deal 2019). For example, if use of the AAS and the GE
tilapia (as well as future GE fish products) is to be
evaluated for contribution to sustainability, it would be
advantageous if this evaluation aligns with the action
plans of the Green Deal.
Sustainable development is globally defined as
development which does not reduce the possibilities of
future generations while simultaneously ensuring the
possibilities of present generations (Brundtland 1987).
Within such a definition, using GE for ensuring a
stable and efficient aquaculture production may be
accepted, if the technology meets the demands of
safety and risk issues, and if it contributes to social and
economc sustainability, e.g., upholding transparency
in the food chain, creating work opportunities and
supporting local communities. Further, the welfare of
animals must be morally acceptable for it to be
sustainable (Blix and Myhr 2021; Broom 2010). In the
Norwegian Animal Welfare Act, all animals are stated
to have intrinsic value independent of their use-value
to humans (Norwegian Animal Welfare Act 2009). If
intrinsic value of animals is also to be taken into
consideration, then a sustainable use of GE cannot
compromise the moral status of the animal (Blix and
Myhr 2021). Defining sustainable development as
something that has to be morally acceptable also
widens the extent to which perspectives of stakehold-
ers and the public are included in evaluation of GE
foods—one of the intentions of non-safety criteria
(Zetterberg and Edvardsson Björnberg 2017).
Public/consumer perception
In 2002, the Eurobarometer on Biotechnology showed
that ‘‘[…] the majority of Europeans [did] not support
GM foods’’ (Gaskell 2003). This attitude did not
change according to the findings of the Eurobarometer
of 2010 (European Commission/TNS 2010). The
concerns for this group of foods were safety for
health, and the issues of whether it was necessary to
apply GM in place of conventional breeding. In 2019,
the concern seemed to have dropped slightly—only
27% of the respondents expressed concern for GM
ingredients in foods or drinks (European Commission/
EFSA 2019). Predictions are for GE products to be
more accepted, especially for products of SDN-1,
which do not involve cis or transgenesis. The main
objectives for using GE are more efficient and
sustainable food production, as well as economic
profitability. In spring 2020, two comprehensive
surveys on public perception of gene technology in
food production were conducted and published in
Norway by the Norwegian Biotechnology Advisory
Board (NBAB 2020), and by SIFO (Consumption
Research Norway) (Bugge 2020). NBAB (N = 2016)
used the term gene editing‘ and showed that the
Norwegian consumers attitudes depend heavily on
what the technology is used for. With regards to use on
animals, the consumers are mainly concerned with
using the technology for improving health in produc-
tion animals and reducing the environmental impact of
protein production industries. Increasing growth or
changing visual traits like color of flesh is regarded
less important amongst the consumers (NBAB 2020).
In the SIFO report (N = 1066), the term GMO was
used in their survey, and 47% of the respondents
expressed that GMOs collided with their view of what
ethical food production looks like. With regards to the
possible negative effects of GMOs, the respondents
were most concerned with nature and ecosystems,




Similar surveys have also been conducted in China.
Recently Cui and Shoemaker (2018) published a
nationwide study (N = 2063) on public perception of
GM food where a majority of the respondents
answered that they are either neutral (46.7%) or
opposed (41.4%) to GM food. The study also
approached linking acceptance to self-percieved
knowledge about GM foods, and states that there
seems to be statistical evidence for a positive connec-
tion between more knowledge and acceptance. The
study also emphasised a lack of trust in the public
towards authorities, but also in biologists opinion, and
further calls for more effort ‘‘[…] to gain confidence,
trust and support from public domain’’ (Cui and
Shoemaker 2018). However, the issues that the
respondents are most concerned with are ‘‘how to
identify GM food’’ and they also want more informa-
tion about ‘‘general scientific knowledge on GM food
safety’’ (Cui and Shoemaker 2018). This underpins the
need for dissemination of knowledge connected to GM
and GE foods, and that the public seeks information
which will not necessarily lead to rejecting GM foods,
but rather for more informed actions.
The results from these surveys indicate that the
discourse on GE foods is not unambiguous. It has been
emphasized that some important issues on which
public acceptance is based are—naturalness, trust,
one’s own health, the environment and the origin of
the food products that we eat (Myskja andMyhr 2020).
There is a need for upholding this discussion about the
origin and type of foods we want to accept and why
these are acceptable (De Graeff et al. 2019). This has
also recently been brought up by the European Group
on Ethics in Science and New Technologies in the
report ‘Ethics of Genome Editing‘. Regarding use of
GE on animals, key identified questions are how the
new technology affects the balance between the three
Rs (refine, replace, reduce) in research, and in
general, how it affects animal welfare as well as what
the implications for biodiversity are (EGE 2021).
Proposed research strategy for relevant data
on food safety RA and regulation
We propose a reseach strategy, which will involve the
active participation of the different disciplines of
molecular biology, bioinformatics (for data on unin-
tended mutations, detection, traceability and surveil-
lance), social sciences and humanities (for data on
consumer perception and sustainability), where social
sciences and humanities are encompassed in the
principles of responsible research and innovation
(RRI); see scheme described in Fig. 1. This will allow
interaction of the different aspects of molecular
biology and bioinformatics with RRI parameters,
e.g. stakeholdersinvolvement especially with regards
to identifying issues of social acceptance and public
ethical justifiability in all aspects of the research. The
strategy emphasizes a departure from research where
the technical science and humanities/social science
components of a project do not interact with each
other, but instead encourage active participation and
learning from each other. Data derivable from the
proposed strategy will enhance transparent research
and consumer knowledge about CRISPR/Cas as well
as influence current global debate on application of
CRISPR/Cas in production, RA and regulation of GE
fish and other GE aquaculture products.
Unintended (off-target & on-target) mutations,
detection, traceability and surveillance
Using disease resistance in GE salmon and the SDN-1
approach as examples, data on unintended off- and on-
target effects as well as data on detection, traceability
and surveillance can be obtained using the scheme de-
scribed in Fig. 1. Gratacap et al. (2019b) have shown
that combining in-vitro and in-vivo large-scale
genome wide screening approach can be used to
identify disease resistance alleles in aquaculture
species. We further propose that studies integrating
new genetic tools in omics can be used to identify
recurring and consistent features of CRISPR/Cas
knockout mutations in salmon and/or salmonid-
derived cells using e.g. disease-related genes of
Atlantic salmon, which can be relevant for detection
and surveillance of GE fish. Non-random repair
outcome of NHEJ of DSBs generated by CRISPR/
Cas9 across cell-lines, experimental replicates and
reagent delivery have been reported (van Overbeek
et al 2016; Shou et al 2018). Repair outcomes were
unique to each target and determined by protospaceer
adjacent motif (PAM) sequence rather than genomic
sequence (van Overbeek et al 2016; Shou et al 2018;
Chakrabarti et al 2019), and are reproducible and
predictable (van Overbeek et al 2016; Shou et al 2018;




proteomics and metabolomics) can be used to profile
the resulting repair-products of CRISPR/Cas9 DSB of
specific genes (e.g. disease resistance genes) with the
aim of identifying unique and recurring characteris-
tics. These features can serve as unique genetic
signatures or molecular markers for detection, tracing
and surveillance of GE fish developed by CRISPR/Cas
SDN-1 approach, providing important data for RA of
food safety. This approach can also be used to identify
off-target mutations and their impact on the GE fish.
Consumer perception
The SIFO and NBAB reports have divergent interests
and methods for asking questions and have thus
interpreted the answers somewhat differently. This has
been emphasized and criticized (Antonsen et al
2020a, b; Carson et al. 2021). The divergent results,
and the criticism of the questions asked indicate that
more work is needed in this area, especially for
mapping consumer perception and acceptability. We
would like to direct a similar reaction to the Chinese
survey on public perception by Cui and Shoemaker
(2018). Analysing large surveys based on a pre-
determined belief that GE organisms are safe to eat
and could be made safe for the environment will not
give a clear understanding of the public perception. It
is important not to write off negative public perception
or lack of acceptability as a lack of knowledge
amongst the public. The NBAB has attempted such a
comparison by asking ‘‘control’’ questions in the
survey, in order to test the respondents‘ level of
knowledge. Some of the criticisms in (Antonsen et al
2020a, b) focused on this and how it not only degrades
public perception, but also that the control questions
used were poorly formulated and misleading. Accep-
tance of GE organisms in food production including
aquaculture is not only a question of risk and physical
effects, it is also about human relation to animals and
nature, instrumentalization of animals, dignity and
Fig. 1 (1) identify potential CRISPR/Cas targets by a
combination of large-scale genome-wide (Gratacap et al.
2019b) as well as proteome- and transcriptome-wide screening
of respective in-vitro and in-vivo pathogen-challenged cells and
tissues of fish; (2) identify and select high priority list of genes
using a combination of CRISPR/Cas-mutations and phenotypic
testing; (3) CRISPR/Cas mutations of the genes highly
prioritized in (2) in fish embryo, coupled with sequencing,
phenotypic testing and characterization to identify population
with desired disease resistance phenotype; (4) molecular
analyses of data generated in (1), (2), (3) for off-target
mutations; (5) Further analyses of data for reproducible and
predictable genetic changes around the target areas that are
recurring and consistent, which can be used to develop genetic
tools for detection, tracing and surveillance of GE fish; (6)
actively integrate, at all stages of the study, key RRI aspects of
purpose, process and outcome, where all actors (policy makers,
research communities, business & industry, representatives
from NGOs and the public) are engaged, e.g., through




characteristics of species, and the […] increasingly
imbalanced power distribution between humans and
animals’’ (De Graeff et al. 2019). This should be
further emphasized in future surveys where stake-
holders and public acceptance of GE are studied; see
Fig. 1, (6), RRI. As shown in the NBAB study, using
technology for improving health in production ani-
mals and reducing the environmental impact may be
considered more acceptable than other purposes.
Future surveys aiming at mapping public percep-
tion should take all this into account. A survey might
not, as seen in recent studies (NBAB 2020; Bugge
2020; Cui and Shoemaker 2018) give clear answers to
whether the public supports or is opposed to the use of
GE animals in food production. Acceptance has
several dimensions and aspects which do not neces-
sarily lead to a clear answer for opposing or supporting
the technology (Van Eenennam and Young 2018). We
encourage future surveys to be aware of this and
instead of asking leading questions, focus the surveys
so that they are open with the aim to identify what the
most pressing concerns are.
Sustainability
Contribution to sustainable development is one of the
non-safety criteria in Norwegian Gene Technology
Act, but the regulation is not yet translated into
guidelines on how to evaluate GE (and GM) fishes.
This could be done by looking at global goals and
strategies such as UN SDGs and EU Green Deal.
Further, a framework for evaluating GE animals
should be based on relevant regulatory frameworks
and policy documents for animal and fish welfare
(Blix and Myhr 2021). In Norway the Animal Welfare
Act equalizes terrestrial and aquatic animals, desig-
nating them with rights to be protected from harm,
stress and strain, in addition to other intrinsic values
(Norwegian Animal Welfare Act 2009). Internation-
ally, fish has not been assigned the same status.
However, the Animal World Health Organization has
developed international standards for fish welfare
contained in the Aquatic Code (The Aquatic Code
2019). A framework for evaluating GE fish should use
the Aquatic Code, which focuses on how to avoid
disease, as a guiding minimum for howwelfare is to be
understood with regards to fish. In addition, it should
also be considered whether the intrinsic value of fish
should be taken into consideration. This could be a
valuable guiding principle (Trøite and Myskja 2018)
for determining whether GE diminishes the integrity
of animal; alternatively what kind of GE is accept-
able? (Blix and Myhr 2021).
Conclusion
The CRISPR/Cas technique is the most popular of the
current GE technologies, therefore, majority of the
expected GE fish products for commercialization will
be products developed by CRISPR/Cas. The technique
has the potential to provide far-reaching solutions to
the several challenges plaquing the fish aquaculture
sector. The current national and international discus-
sions is on whether products arising from GE
techniques, especially CRISPR/Cas, should be regu-
lated. Given the enormous importance of the matter,
decisions whether to regulate or not, and more
importantly, how to regulate GE fish products, should
be based on knowledge derived from profound
scientific research. The current RA frameworks do
not cover CRISPR/Cas GE fish. This will challenge
the existing frameworks with regards to unintended
and pleiotropic effects as well as detection, identifi-
cation, tracing and monitoring of GE fish in the case of
inadvertent or intentional release into the environ-
ment. The essential knowledge for crucial decisions
and robust RA is not available. Research strategies
that take advantage of the new molecular biology
techniques, including transcriptomics, proteomics and
metabolomics, which have become more advanced
and cheaper, will contribute these knowledge-needs.
Further, inclusion of animal welfare, ethical, societal
and sustainability aspects in the policy decision
process will complement risk assessment and ensure
that cultural and societal interests are taken into
consideration.
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